The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd007419.pub3 |
| Pubmed ID | |
| Authors |
Virgili G, Parravano M, Menchini F, Brunetti M, Gianni Virgili, Mariacristina Parravano, Francesca Menchini, Massimo Brunetti, Virgili, Gianni, Parravano, Mariacristina, Menchini, Francesca, Brunetti, Massimo |
| Abstract |
Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Although grid or focal laser photocoagulation has been shown to reduce the risk of visual loss in DMO or clinically significant macular oedema (CSMO), vision is rarely improved. Antiangiogenic therapy with anti-vascular endothelial growth factor (anti-VEGF) modalities has recently been proposed for improving vision in people with DMO. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | 2% |
| Ecuador | 1 | <1% |
| Austria | 1 | <1% |
| Brazil | 1 | <1% |
| Canada | 1 | <1% |
| Singapore | 1 | <1% |
| China | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 122 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 17% |
| Student > Master | 22 | 17% |
| Student > Bachelor | 18 | 14% |
| Student > Ph. D. Student | 13 | 10% |
| Student > Postgraduate | 11 | 8% |
| Other | 22 | 17% |
| Unknown | 24 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 62 | 47% |
| Agricultural and Biological Sciences | 11 | 8% |
| Nursing and Health Professions | 7 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 5% |
| Psychology | 3 | 2% |
| Other | 15 | 11% |
| Unknown | 28 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 February 2013.
All research outputs
#16,874,917
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#11,474
of 13,156 outputs
Outputs of similar age
#187,029
of 287,251 outputs
Outputs of similar age from Cochrane database of systematic reviews
#166
of 197 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,251 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 197 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.